Genetic mechanism underlying the resilience to Alzheimer's disease and its prospect for clinical application.
10.3760/cma.j.cn511374-20210828-00699
- Author:
Fan ZENG
1
;
Yuhuan MA
;
Jun WANG
;
Yanjiang WANG
Author Information
1. Department of Neurology and Center for Clinical Neuroscience, Daping Hospital (Army Medical Center), Army Medical University, Chongqing 400042, China. zengfan326@163.com.
- Publication Type:Journal Article
- MeSH:
Aged;
Humans;
Alzheimer Disease/genetics*;
Neurodegenerative Diseases;
Cognitive Dysfunction
- From:
Chinese Journal of Medical Genetics
2022;39(12):1419-1423
- CountryChina
- Language:Chinese
-
Abstract:
As the most common neurodegenerative disease, Alzheimer's disease (AD) is characterized by progressive cognitive decline and is a major threat to the health of elderly worldwide. Aside from its pathogenesis, delineation of the protective mechanism of AD is also critical for the etiological treatment. AD resilience refers to a protective mechanism which can maintain the cognitive intactness of patients despite of genetic risk factors and/or related pathology. Studies on the genetic mechanism of AD resilience are of great importance for revealing novel mechanisms and therapeutic targets, as well as optimizing polygenic risk score which can facilitate early identification and intervention for individuals at risk.
